Gut Microbiome in Cardiovascular Disease and Heart Failure: Seeing the Iceberg Below Its Surface
- PMID: 37407156
- DOI: 10.1016/j.jchf.2023.05.011
Gut Microbiome in Cardiovascular Disease and Heart Failure: Seeing the Iceberg Below Its Surface
Keywords: cardiovascular disease; diet; gut microbiome; heart failure; imidazole propionate.
Conflict of interest statement
Funding Support and Author Disclosures Dr Lanfear is supported in part by grants from the National Institutes of Health (P50MD017351, R01HL132154); has received research funding or support from Amgen, AstraZeneca, Eli Lilly, Illumina, Pfizer, and SomaLogic; and has acted as consultant to ACI Clinical (Abbott Laboratories), AstraZeneca, Cytokinetics, Duke Clinical Research Institute (CONNECT-HF), Illumina, Janssen, Martin Pharmaceuticals, Ortho Clinical Diagnostics, Otsuka, and Vicardia. Dr Mamic is supported in part by an American Heart Association (AHA) Career Development Award (ID 856341).
Comment on
-
Microbially Produced Imidazole Propionate Is Associated With Heart Failure and Mortality.JACC Heart Fail. 2023 Jul;11(7):810-821. doi: 10.1016/j.jchf.2023.03.008. Epub 2023 Apr 26. JACC Heart Fail. 2023. PMID: 37115134 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
